Literature DB >> 18174879

Decay data and production yields of some non-standard positron emitters used in PET.

S M Qaim1.   

Abstract

The increasing significance of non-standard positron emission tomography (PET) nuclides in medicine is briefly outlined. The decay data of those radionuclides are generally well known, except for the positron emission intensity (Ibeta+) in a few cases. The recent precise measurements on the Ibeta+ values for (64)Cu, (76)Br, (120)I and (124)I are described. Some general aspects of cyclotron production of radionuclides are discussed. The need of some fundamental nuclear chemistry research with regard to the development of a new production route is demonstrated. An accurate knowledge of the excitation function of a nuclear reaction is essential to optimize the production route. The yield of a product calculated from the excitation function of a reaction gives the maximum achievable yield. Such yields are given for 24 radionuclides presently attracting attention. The experimental yields are always lower than the theoretical values, calling upon constant improvements in targetry and chemical processing procedures. Many of the non-standard PET nuclides, like (64)Cu, (86)Y, (94m)Tc, (124)I, etc. are produced in good yields at low energy cyclotrons while for production of some other radionuclides (e.g. 52Fe, 73Se, 83Sr, etc.) an intermediate energy cyclotron is required.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18174879

Source DB:  PubMed          Journal:  Q J Nucl Med Mol Imaging        ISSN: 1824-4785            Impact factor:   2.346


  11 in total

1.  Cu(I)-assisted click chemistry strategy for conjugation of non-protected cross-bridged macrocyclic chelators to tumour-targeting peptides.

Authors:  Zhengxin Cai; Barbara T Y Li; Edward H Wong; Gary R Weisman; Carolyn J Anderson
Journal:  Dalton Trans       Date:  2015-03-07       Impact factor: 4.390

Review 2.  Whole animal imaging.

Authors:  Gurpreet Singh Sandhu; Luis Solorio; Ann-Marie Broome; Nicolas Salem; Jeff Kolthammer; Tejas Shah; Chris Flask; Jeffrey L Duerk
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010 Jul-Aug

Review 3.  Unconventional nuclides for radiopharmaceuticals.

Authors:  Jason P Holland; Matthew J Williamson; Jason S Lewis
Journal:  Mol Imaging       Date:  2010-02       Impact factor: 4.488

Review 4.  86Y based PET radiopharmaceuticals: radiochemistry and biological applications.

Authors:  Tapan K Nayak; Martin W Brechbiel
Journal:  Med Chem       Date:  2011-09       Impact factor: 2.745

5.  (64)Cu-labeled CB-TE2A and diamsar-conjugated RGD peptide analogs for targeting angiogenesis: comparison of their biological activity.

Authors:  Lihui Wei; Yunpeng Ye; Thaddeus J Wadas; Jason S Lewis; Michael J Welch; Samuel Achilefu; Carolyn J Anderson
Journal:  Nucl Med Biol       Date:  2009-04       Impact factor: 2.408

Review 6.  Radioimmunoimaging with longer-lived positron-emitting radionuclides: potentials and challenges.

Authors:  Tapan K Nayak; Martin W Brechbiel
Journal:  Bioconjug Chem       Date:  2009-05-20       Impact factor: 4.774

7.  64Cu-labeled somatostatin analogues conjugated with cross-bridged phosphonate-based chelators via strain-promoted click chemistry for PET imaging: in silico through in vivo studies.

Authors:  Zhengxin Cai; Qin Ouyang; Dexing Zeng; Kim N Nguyen; Jalpa Modi; Lirong Wang; Alexander G White; Buck E Rogers; Xiang-Qun Xie; Carolyn J Anderson
Journal:  J Med Chem       Date:  2014-07-11       Impact factor: 7.446

8.  The Beginning and Development of the Theranostic Approach in Nuclear Medicine, as Exemplified by the Radionuclide Pair 86Y and 90Y.

Authors:  Frank Rösch; Hans Herzog; Syed M Qaim
Journal:  Pharmaceuticals (Basel)       Date:  2017-06-20

Review 9.  Chelators for copper radionuclides in positron emission tomography radiopharmaceuticals.

Authors:  Zhengxin Cai; Carolyn J Anderson
Journal:  J Labelled Comp Radiopharm       Date:  2013-12-18       Impact factor: 1.921

10.  Pilot Study of 64Cu(I) for PET Imaging of Melanoma.

Authors:  Lei Jiang; Yingfeng Tu; Xiang Hu; Ande Bao; Hao Chen; Xiaowei Ma; Tim Doyle; Hongcheng Shi; Zhen Cheng
Journal:  Sci Rep       Date:  2017-05-31       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.